On Apr. 14, 1993, the Earl Davie/ZymoGenetics Endowed Chair of Biochemistry at the University of Washington was established…
On Apr. 1, 1993, the FDA approved Amgen’s Epogen/Procrit for the treatment of anemia due to the effects…
On Mar. 30, 1993, the U.S. Food and Drug Administration (FDA) approved a new Haemophilus b conjugate vaccine,…
In 1993, the U.S. Food and Drug Administration (FDA) declared genetically-engineered foods are not inherently dangerous and do…
In 1993, The U.S. Food and Drug Administration (FDA) added new CBER reviewers to streamline biologics review. User…
In 1993, Genentech drug Nutropin was approved by the U.S. Food and Drug Administration (FDA).
On Dec. 18, 1992, Taxol (paclitaxel), an anticancer drug extracted from the bark of the Pacific yew, received…
On Dec. 10, 1992, the Japanese encephalitis (JE) virus vaccine inactivated (JE-Vax by Research Foundation for Microbial Diseases…
On Oct. 7, 1992, all U.S. mammography facilities, except those managed by the Department of Veterans Affairs, must…
On Sept. 3, 1992, PathoGenesis Corp. was founded by Robert Nowinski. The company, based in Seattle, developed an…
On Feb. 29, 1992, the U.S. Food and Drug Administration (FDA)Â announced new food labeling rules. The purpose…
In 1992, President George Bush signed the Prescription Drug User Fee Act (PDUFA) and under the Clinton administration,…
In 1992, the University of Iowa (UI) Research Foundation received its first U.S. patent on the CMV promoter,…
On Dec. 17, 1991, the Diphtheria and tetanus toxoids and acellular pertussis vaccine (Acel-Imune by Lederle) was licensed…
On Oct. 9, 1991, Bristol-Myers’ VIDEX (didanosine) was approved by the U.S. Food and Drug Administration for the…
On Aug. 26, 1991, Cellpro announced its initial public offering. CellPro, founded in Bothell, Washington, developed the CEPRATE…
On Jun. 6, 1991, ICOS completed its IPO at at $8.00 per share for a total of $36…
In March 1991, Immunex announced it had received U.S. Food and Drug Administration (FDA) approval to market Leukine…
On Feb. 22, 1991, the Food and Drug Administration (FDA) announced that it had approved Amgen’s two white…
In 1991, the policy for protection of human subjects in research, promulgated in 1981 by the U.S. Food…
In 1991, regulations published to Accelerate the Review of Drugs for life-threatening diseases. In Decemebr, 1992, the FDA…
In 1991, Bristol Myers Squibb’s cardiovascular medicines, PRAVACHOL (pravastin sodium) and MONOPRIL (fosinopril sodium) were approved by the…
On Dec. 13, 1990, the U.S. Food and Drug Administration (FDA) approved Haemophilus b Conjugate Vaccine (Meningococcal Protein…
On Nov. 28, 1990, the Safe Medical Devices Act was passed, requiring nursing homes, hospitals, and other facilities…
On Nov. 8, 1990, the Nutrition Labeling and Education Act was signed into law by President George H….
On Dec. 29, 1989, the U.S. Food and Drug Administration (FDA) approved Oculinum’s (onabotulinumtoxinA) for treatment of strabismus…
On Nov. 24, 1989, the U.S. Food and Drug Administration (FDA) issued a nationwide recall of all over-the-counter…
On Aug. 28, 1989, a second recombinant hepatitis B vaccine, Engerix-B (SmithKlineBeecham), was approved for use in the…
On Jun. 1, 1989, the FDA approved Amgen’s Epogen/Procrit for the treatment of anemia associated with chronic renal…
On Mar. 3, 1989, the U.S. Food and Drug Administration (FDA) approved Bristol-Myers’ PARAPLATIN (carboplatin) for the treatment…